Document:

Exhibit 10.6

 

PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT

 

THIS PRIVATE PLACEMENT WARRANTS PURCHASE
AGREEMENT, dated as of [            ], 2020 (as it may from time to time
be amended, this “Agreement”), is entered into by and between Spartan Acquisition Corp. II, a Delaware corporation
(the “Company”), and Spartan Acquisition Sponsor II LLC, a Delaware limited liability company (the “Purchaser”).

 

WHEREAS, the Company intends to consummate
an initial public offering of the Company’s units (the “Public Offering”), each unit consisting of one share
of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), and one-third of one
redeemable warrant as set forth in the Company’s registration statement on Form S-1, filed with the Securities and Exchange
Commission (the “SEC”), File Number 333-[     ] (the “Registration Statement”),
under the Securities Act of 1933, as amended (the “Securities Act”). Each whole warrant entitles the holder to purchase
one share of Common Stock at an exercise price of $11.50 per share. The Purchaser has agreed to purchase an aggregate of [           
] warrants (or up to [             ] warrants if the over-allotment option
in connection with the Public Offering is exercised in full) (the “Private Placement Warrants”), each whole Private
Placement Warrant entitling the holder to purchase one share of Common Stock at an exercise price of $11.50 per share.

 

NOW THEREFORE, in consideration of the
mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section 1. Authorization, Purchase and
Sale; Terms of the Private Placement Warrants.

 

A. Authorization of the Private
Placement Warrants. The Company has duly authorized the issuance and sale of the Private Placement Warrants to the Purchaser.

 

B. Purchase and Sale of the Private
Placement Warrants.

 

(i) On the date that is one business day
prior to the date of the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by the
Purchaser and the Company (the “Initial Closing Date”), the Company shall issue and sell to the Purchaser, and the
Purchaser shall purchase from the Company, [     ] Private Placement Warrants at a price of $1.50 per
warrant for an aggregate purchase price of $[     ] (the “Purchase Price”). The Purchaser
shall pay the Purchase Price by wire transfer of immediately available funds in accordance with the Company’s wiring instructions.
On the Initial Closing Date, upon the payment by the Purchaser of the Purchase Price, the Company shall, at its option, deliver
a certificate evidencing the Private Placement Warrants purchased on such date duly registered in the Purchaser’s name to
the Purchaser, or effect such delivery in book-entry form.

 

     

     

    

 

(ii) On the date that is one business day
prior to the date of the consummation of the closing of the over-allotment option in connection with the Public Offering or on
such earlier time and date as may be mutually agreed by the Purchaser and the Company (each such date, an “Over-allotment
Closing Date”, and each Over-allotment Closing Date (if any) and the Initial Closing Date being sometimes referred to herein
as a “Closing Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the
Company, up to [     ] Private Placement Warrants, in the same proportion as the amount of the over-allotment
option that is exercised, at a price of $1.50 per warrant for an aggregate purchase price of up to $[     ]
(if the over-allotment option in connection with the Public Offering is exercised in full) (the “Over-allotment Purchase
Price”). The Purchaser shall pay the Over-allotment Purchase Price by wire transfer of immediately available funds in accordance
with the Company’s wiring instructions. On the Over-allotment Closing Date, upon the payment by the Purchaser of the Over-allotment
Purchase Price, the Company shall, at its option, deliver a certificate evidencing the Private Placement Warrants purchased on
such date duly registered in the Purchaser’s name to the Purchaser, or effect such delivery in book-entry form. 

 

C. Terms of the Private Placement
Warrants.

 

(i) Each Private Placement Warrant shall
have the terms set forth in a Warrant Agreement to be entered into by the Company and a warrant agent, in connection with the Public
Offering (the “Warrant Agreement”).

 

(ii) At the time of the closing of the
Public Offering, the Company and the Purchaser shall enter into a registration rights agreement (the “Registration Rights
Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser relating to the Private
Placement Warrants and the shares of Common Stock underlying the Private Placement Warrants.

 

Section 2. Representations and Warranties
of the Company. As a material inducement to the Purchaser to enter into this Agreement and purchase the Private Placement Warrants,
the Company hereby represents and warrants to the Purchaser (which representations and warranties shall survive each Closing Date)
that:

 

A. Organization and Corporate Power.
The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and
is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have a material
adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite corporate
power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.

 

    2

     

    

 

B. Authorization; No Breach.

 

(i) The execution, delivery and performance
of this Agreement and the Private Placement Warrants have been duly authorized by the Company as of the Closing Date. This Agreement
constitutes the valid and binding obligation of the Company, enforceable in accordance with its terms, subject to bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’
rights and to general equitable principles (whether considered in a proceeding in equity or law). Upon issuance in accordance with,
and payment pursuant to, the terms of the Warrant Agreement and this Agreement, the Private Placement Warrants will constitute
valid and binding obligations of the Company, enforceable in accordance with their terms as of the Closing Date, subject to bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting
creditors’ rights and to general equitable principles (whether considered in a proceeding in equity or law).

 

(ii) The execution and delivery by the
Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private Placement Warrants, the issuance
of the shares of Common Stock upon exercise of the Private Placement Warrants and the fulfillment of and compliance with the respective
terms hereof and thereof by the Company, do not and will not as of the Closing Date (a) conflict with or result in a breach of
the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of any lien, security interest,
charge or encumbrance upon the Company’s capital stock or assets under, (d) result in a violation of, or (e) require any
authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any court or administrative
or governmental body or agency pursuant to the Certificate of Incorporation of the Company or the Bylaws of the Company, or any
material law, statute, rule or regulation to which the Company is subject, or any agreement, order, judgment or decree to which
the Company is subject, except for any filings required after the date hereof under federal or state securities laws.

 

C. Title to Securities. Upon
issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the shares of Common Stock issuable
upon exercise of the Private Placement Warrants will be duly and validly issued, fully paid and non-assessable. Upon issuance in
accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Purchaser will have good title to the
Private Placement Warrants and the shares of Common Stock issuable upon exercise of such Private Placement Warrants, free and clear
of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder and under the other agreements
contemplated hereby, (ii) transfer restrictions under federal and state securities laws, and (iii) liens, claims or encumbrances
imposed due to the actions of the Purchaser.

 

D. Governmental Consents. No
permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is required in connection
with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company of any other transactions
contemplated hereby. 

 

D. Regulation D Qualification.
Neither the Company nor, to its knowledge, any of its affiliates,

directors or beneficial stockholders of
20% or more of its outstanding securities, has experienced a

disqualifying event as enumerated pursuant
to Rule 506(d) of Regulation D under the Securities Act.

 

    3

     

    

 

Section 3. Representations and Warranties
of the Purchaser. As a material inducement to the Company to enter into this Agreement and issue and sell the Private Placement
Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations and warranties shall
survive each Closing Date) that:

 

A. Organization and Requisite Authority.
The Purchaser possesses all requisite power and authority necessary to carry out the transactions contemplated by this Agreement.

 

B. Authorization; No Breach.

 

(i) This Agreement constitutes a valid
and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’ rights
and to general equitable principles (whether considered in a proceeding in equity or law).

 

(ii) The execution and delivery by the
Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser does not and shall not
as of each Closing Date conflict with or result in a breach by the Purchaser of the terms, conditions or provisions of any agreement,
instrument, order, judgment or decree to which the Purchaser is subject.

 

C. Investment Representations.

 

(i) The Purchaser is acquiring the Private
Placement Warrants and, upon exercise of the Private Placement Warrants, the shares of Common Stock issuable upon such exercise
(collectively, the “Securities”), for the Purchaser’s own account, for investment purposes only and not with
a view towards, or for resale in connection with, any public sale or distribution thereof.

 

(ii) The Purchaser is an “accredited
investor” as such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act.

 

(iii) The Purchaser understands that the
Securities are being offered and will be sold to it in reliance on specific exemptions from the registration requirements of the
United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s
compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the availability of
such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv) The Purchaser did not decide to enter
into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule 502(c) under the
Securities Act.

 

(v) The Purchaser has been furnished with
all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of
the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to ask questions of
the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities involves a
high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to the acquisition of the Securities.

 

(vi) The Purchaser understands that no
United States federal or state agency or any other government or governmental agency has passed on or made any recommendation or
endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser nor have such
authorities passed upon or endorsed the merits of the offering of the Securities.

 

    4

     

    

 

(vii) The Purchaser understands that: (a)
the Securities have not been and are not being registered under the Securities Act or any state securities laws, and may not be
offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance on an exemption
therefrom; (b) except as specifically set forth in the Registration Rights Agreement, neither the Company nor any other person
is under any obligation to register the Securities under the Securities Act or any state securities laws or to comply with the
terms and conditions of any exemption thereunder; and (c) Rule 144 adopted pursuant to the Securities Act will not be available
for resale transactions of Securities prior to a Business Combination and may not be available for resale transactions of Securities
after a Business Combination.

  

(viii) The Purchaser has such knowledge
and experience in financial and business matters, knows of the high degree of risk associated with investments in the securities
of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment in the
Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder for an
indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and
will have no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities.
The Purchaser can afford a complete loss of its investment in the Securities.

 

Section 4. Conditions of the Purchaser’s
Obligations. The obligations of the Purchaser to purchase and pay for the Private Placement Warrants are subject to the fulfillment,
on or before each Closing Date, of each of the following conditions:

 

A. Representations and Warranties.
The representations and warranties of the Company contained in Section 2 shall be true and correct at and as of such Closing Date
as though then made.

 

B. Performance. The Company
shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by it on or before such Closing Date.

 

C. No Injunction. No litigation,
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over
the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or
the Warrant Agreement.

 

D. Warrant Agreement. The Company
shall have entered into a Warrant Agreement with a warrant agent on terms satisfactory to the Purchaser.

 

    5

     

    

 

Section 5. Conditions of the Company’s
Obligations. The obligations of the Company to the Purchaser under this Agreement are subject to the fulfillment, on or before
each Closing Date, of each of the following conditions:

 

A. Representations and Warranties.
The representations and warranties of the Purchaser contained in Section 3 shall be true and correct at and as of such Closing
Date as though then made.

 

B. Performance. The Purchaser
shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by the Purchaser on or before such Closing Date.

 

C. Corporate Consents. The
Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance of this Agreement
and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder.

 

D. No Injunction. No litigation,
statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over
the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or
the Warrant Agreement.

 

E. Warrant Agreement. The Company
shall have entered into a Warrant Agreement with a warrant agent on terms satisfactory to the Company.

 

Section 6. Termination. This Agreement
may be terminated at any time after [     ], 2020 upon the election by either the Company or the Purchaser
upon written notice to the other party if the closing of the Public Offering does not occur prior to such date. 

 

Section 7. Survival of Representations
and Warranties. All of the representations and warranties contained herein shall survive each Closing Date.

  

Section 8. Definitions. Terms used
but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the Registration Statement.

 

Section 9. Miscellaneous.

 

A. Successors and Assigns.
Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf of any
of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed
or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement, other than
assignments by the Purchaser to affiliates thereof (including, without limitation one or more of its members).

 

B. Severability. Whenever possible,
each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if
any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective
only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

    6

     

    

 

C. Counterparts. This Agreement
may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than one party, but
all such counterparts taken together shall constitute one and the same agreement. In the event that any signature is delivered
by facsimile transmission or by e-mail delivery of a “pdf” format data file, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if
such facsimile or “.pdf” signature page were an original thereof.

 

D. Descriptive Headings; Interpretation.
The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive part of this Agreement.
The use of the word “including” in this Agreement shall be by way of example rather than by limitation.

 

E. Governing Law. This Agreement
shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be construed in accordance
with the internal laws of the State of New York.

 

F. Amendments. This Agreement
may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties hereto.

 

[Signature page follows] 

 

    7

     

    

 

IN WITNESS WHEREOF, the parties hereto
have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	SPARTAN ACQUISITION CORP. II

 

	 	By: 	 
	 	 	Name:  	Geoffrey Strong
	 	 	Title:	Chief Executive Officer

 

	 	PURCHASER:
	 	SPARTAN ACQUISITION SPONSOR II LLC

 

	 	By:	 
	 	 	Name:  	Geoffrey Strong
	 	 	Title:	Chief Executive Officer

 

[Signature Page to Private Placement
Warrants Purchase Agreement]pch-ex101_53.htm

Exhibit 10.1

 

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT THAT IS MARKED BY [***] HAS BEEN OMITTED BECAUSE IT (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

Contractholder:PotlatchDeltic Corporation

 

Effective Date:March 6, 2020

 

Date of Issue:October 16, 2020

 

Contract Number:[***]

 

NEW YORK LIFE WILL PAY the benefits provided by this contract, subject to its terms and conditions.

This contract is made in consideration of the payment of a Contribution in the amount of $[***] receipt of which is hereby acknowledged.

The benefits, provisions and conditions set forth on the following pages are part of this contract.

IN WITNESS WHEREOF, New York Life has caused this contract to be executed on its Date of Issue.

 

 

GROUP  ANNUITY  CONTRACT

SINGLE  CONTRIBUTION            NON  CONTRIBUTORY

NON-PARTICIPATING  ANNUITIES

			
	
 
Chairman and CEO
	

Secretary

 

 

/s/ Andrew Cohen

	
Countersignature
	

 

 

 

TABLE OF CONTENTS

 

	
ARTICLE
	
PAGE

	
 
	
 
	
 
	
 

	
I.
	
 
	
DEFINITIONS
	
1

	
 
	
 
	
 
	
 
	
 

	
II.
	
 
	
BENEFITS
	
 

	
 
	
 
	
 
	
Annuity Benefits
	
3

	
 
	
 
	
 
	
 
	
 

	
III.
	
 
	
PAYMENT OF BENEFITS
	
 

	
 
	
 
	
 
	
Method of Payment of Annuity Benefit
	
4

	
 
	
 
	
 
	
Beneficiary
	
4

	
 
	
 
	
 
	
Payment in Event of Incapacity
	
4

	
 
	
 
	
 
	
Evidence of Survival
	
4

	
 
	
 
	
 
	
 
	
 

	
IV.
	
 
	
GENERAL PROVISIONS
	
 

	
 
	
 
	
 
	
Contract
	
5

	
 
	
 
	
 
	
Certificates
	
5

	
 
	
 
	
 
	
Misstatements and Redetermination of Annuity Payments
	
5

	
 
	
 
	
 
	
Information to be Furnished
	
5

	
 
	
 
	
 
	
Liability of New York Life
	
6

	
 
	
 
	
 
	
Assignability
	
6

	
 
	
 
	
 
	
Jurisdiction
	
6

	
 
	
 
	
 
	
 
	
 

	
PARTICIPANT LISTING
	
 

 

 

 

 

 

-i-

 

ARTICLE I:  DEFINITIONS

 

Whenever the terms set forth below are used in this contract, they will have the meaning set forth below unless a different meaning is plainly required by the context.  Masculine pronouns will refer to both males and females and the singular will include the plural unless the context indicates otherwise.  Headings of articles and sections are used for convenience of reference and, in case of conflict, the text of the contract, rather than such headings, will control.

 

	
1.1 
	
PLAN means the Potlatch Salaried Retirement Plan, Potlatch Hourly Retirement Plan, Potlatch Hourly Non Represented Retirement Plan, and Retirement Plan of Deltic Timber Corporation, as they existed on March 6, 2020.

	
1.2
	
PARTICIPANT means any person designated by the Employer as a retired participant of the Plan who is entitled to benefits under this contract pursuant to the Plan.

	
1.3
	
LIFE ANNUITY means an annuity consisting of [***]

	
1.4
	
25%, 50%, 75% or 100% LIFE JOINT AND SURVIVOR ANNUITY means an annuity consisting of [***]

	
1.5
	
CERTAIN AND LIFE ANNUITY means an annuity consisting of [***]

 

	
1.6
	
PURE CERTAIN ANNUITY means an annuity consisting of [***]

 

	
1.7
	
SOCIAL SECURITY LEVEL INCOME OPTION means an annuity consisting of [***]

 

	
1.8
	
EMPLOYER means PotlatchDeltic Corporation.

 

 

-1-

 

ARTICLE II:  BENEFITS

 

2.1ANNUITY BENEFITS

   a.Annuity Benefits to Commence on May 1, 2020

	
 
	

	
Each Participant and each joint annuitant (as indicated on the Participant Listing) or beneficiary of a deceased Participant who was receiving or became entitled to receive retirement benefit payments under the Plan immediately prior to March 6, 2020 and is living on March 6, 2020 will be entitled to an annuity benefit under this contract commencing on May 1, 2020.  The amount, form and duration of such benefit will be determined pursuant to the provisions of the Plan, as per the attached listing by the Contractholder to New York Life.

   

-2-

 

ARTICLE III:  PAYMENT OF BENEFITS

 

3.1METHOD OF PAYMENT OF ANNUITY BENEFIT

The annuity benefit provided under the terms of this contract will be payable by check at the Home Office of New York Life.  Such annuity benefit payments will be due and payable monthly in an amount equal to 1/12th of the annual annuity benefit.

3.2BENEFICIARY

For Certain and Life Annuity and Pure Certain Annuity [***]

If there is no surviving designated beneficiary at the date of death, any benefit payable will be paid to the spouse, if living, or in equal shares to the living members of the first of the following classes of surviving relatives: children; parents; brothers and sisters; or the estate of the deceased.

A Participant may designate a beneficiary or change a previous designation only by written notice.  No such designation or change will be effective until received by New York Life, but, once it has been so received, it will take effect as of the date the notice was signed, subject to any payment made or other action taken before such receipt.  A beneficiary designation made under the Plan prior to the Effective Date as communicated by the Contractholder to New York Life will continue in force until changed by the Participant in accordance with the foregoing.

[***]

3.3PAYMENT IN EVENT OF INCAPACITY [***]

3.4EVIDENCE OF SURVIVAL

When any payment under this contract is contingent upon a person being alive on any date, New York Life may require evidence satisfactory to it that such person was alive on said date.

-3-

 

ARTICLE IV:  GENERAL PROVISIONS

 

4.1CONTRACT

The entire contract between New York Life and the Contractholder will consist of this contract including Participant Listing and Exhibits, if any, and the application of the Contractholder, a copy of which is attached hereto.  No agent or other person except an Executive Officer of New York Life has authority to make, endorse, or modify this contract on behalf of New York Life or to waive any of New York Life’s rights or requirements, and no modification of this contract will be valid unless evidenced by an amendment to the contract signed by the Contractholder and an Executive Officer of New York Life.  No such modification will require the consent of any Participant or other person or entity entitled to a benefit, provided that such modification does not affect the amount, or the terms and conditions of payment, of any annuity provided with respect to the Participant under this contract.

4.2CERTIFICATES

	
 
	

	
New York Life will issue to each Participant when his annuity benefit commences, an individual certificate setting forth the amount of such annuity benefit and the terms of its payment.

4.3MISSTATEMENTS AND REDETERMINATION OF ANNUITY PAYMENTS

If the age, sex or form of annuity payments with respect to any Participant is found to have been misstated, then, (unless an equitable adjustment satisfactory to New York Life and the Contractholder is made) the amount of annuity payable by New York Life will be as may be provided by the amount initially applied to the purchase of any annuity and determined as of the Effective Date of this contract based on the misstated information, but redetermined on the basis of the correct age, sex and form of annuity payments.  Any adjustment of terms or amounts of payments made in accordance with the preceding statement will be conclusive upon any Participant affected thereby.

Upon redetermination of annuity amounts in accordance with the preceding paragraph, any overpayments by New York Life due to any misstatement that gave reason to the redetermination will be deducted from amounts thereafter payable to the Participant, or  other person or entity entitled to a benefit and any underpayments will be paid in full with the next payment due the Participant or other person or entity entitled to a benefit.

4.4INFORMATION TO BE FURNISHED

(i) New York Life will be furnished data required for the administration of this contract, including data required by the Retirement Equity Act of 1984 or any other Act and applicable regulations.

 

 

-4-

 

ARTICLE IV:  GENERAL PROVISIONS (continued)

 

(ii) New York Life reserves the right to inquire into the accuracy and completeness of any such data and to make a reasonable inspection of the records upon which such data are based, but it is under no obligation to make any such inquiry or inspection.

 

(iii) All references in this contract to action taken pursuant to the Plan means actions reported to New York Life as having been taken by the Employer in accordance with the provisions of the Plan.  New York Life is entitled to rely conclusively on the accuracy and completeness of data reported to it by the Employer, including the determination as to whether an individual is entitled to a benefit and the amount and form of such benefit.

4.5LIABILITY OF NEW YORK LIFE

New York Life is not a party to the Plan and its obligations are limited to those set forth in this contract. The liability of New York Life, with respect to a Participant or other person or entity entitled to a benefit, will be limited to the payment of any benefit due such person or entity under the terms of the contract and in force at the time such payment becomes due.

4.6ASSIGNABILITY

The Contractholder may assign this Contract, in whole or in part, provided the assignee holds the Contract or any interest therein as an asset of a pension, profit-sharing or other retirement plan maintained by a corporate employer which meets the qualification requirements of Section 401(a) of the Internal Revenue Code, as amended, or to any other assignee provided that, in the opinion of New York Life’s legal advisor, this Contract retains its exempt status under the Securities Act of 1933, or any other federal or state securities laws.  Any other attempted assignment of this Contract or any interest therein will be null and void, and will not be binding on New York Life.

Any assignment of this Contract, or of any interest therein, must be filed with New York Life.  Any such assignment will be subject to any payment made or other action taken by New York Life before the assignment is received and acknowledged as accepted by New York Life.  New York Life assumes no responsibility for the validity of any assignment.

No other person entitled to a benefit under this Contract will have the right to assign, transfer, hypothecate, encumber, commute or anticipate his interest in such benefit and, to the extent permitted by law, no benefit will be liable to seizure or application by operation of law to pay any debt or liability incurred by him, except to the extent as may be required under the terms of a Qualified Domestic Relations Order as such term is defined under the Retirement Equity Act of 1984 and applicable regulations.

4.7JURISDICTION

This contract is delivered in and subject to the laws of the state of Washington.

-5-

 

PARTICIPANT LISTING

 

Individuals listed below are entitled to the indicated annuity benefit payments by New York Life Insurance Company commencing on May 1, 2020. 

															
	
 
	
 
	
 
	
 
	
 
	
 
					
	
UNIQUE_ID
	
CERTIFICATE #
	
NAME
	
SOCIAL SECURITY NUMBER
	
SEX
	
DATE OF BIRTH
	
MONTHLY BENEFIT
	
FORM OF ANNUITY
	
JOINT ANNUITANT NAME
	
JOINT ANNUITANT SEX
	
JOINT ANNUITANT DOB
	
LAST GUARANTEED PAYMENT DATE / SSLIO LAST PAYMENT DATE

	
[***]
	
[***]
	
[***]
	
[***]
	
[***]
	
[***]
	
[***]
	
[***]
	
[***]
	
[***]
	
[***]
	
[***]

 

 

 

 

APPLICATION

 

PotlatchDeltic Corporation as Contractholder

whose Main Office Address is 601 W 1st Ave, Suite 1600

Spokane, WA 99201

 

hereby makes application to New York Life Insurance Company

51 Madison Avenue

New York, NY  10010

 

for Group Annuity Contract No.[***], the terms of which are hereby approved and accepted by the Contractholder to take effect on the Effective Date specified in the Contract.

 

 

It is agreed that this application supersedes any Statement of Understanding or application for this Contract previously signed by the Contractholder.

 

 

Executed at ________________________Contractholder

 

 

	
 
	
On October 16, 2020                                
	
By  /s/ Jerald W. Richards  VP-CFO                                                                       (Signature and Title)
	
 

 

Agent:  ______________________________________________

 

 

Countersignature:  ______________________________________________

(Resident Licensed Agent where Required)

 

 

This copy is part of the entire contract and a duplicate original of the

contract including this Application is to be returned to New York Life.

 

It is a crime to knowingly provide false, incomplete, or misleading information to an insurance company for the purpose of defrauding the company.  Penalties include imprisonment, fines and denial of insurance benefits.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}]]